IMMUNOLOGICAL PARAMETERS IN PERIPHERAL-BLOOD OF PATIENTS WITH RENAL-CELL CARCINOMA BEFORE AND AFTER NEPHRECTOMY

被引:32
作者
DADIAN, G [1 ]
RICHES, PG [1 ]
HENDERSON, DC [1 ]
TAYLOR, A [1 ]
MOORE, J [1 ]
ATKINSON, H [1 ]
GORE, ME [1 ]
机构
[1] ROYAL MARSDEN HOSP,LONDON,ENGLAND
来源
BRITISH JOURNAL OF UROLOGY | 1994年 / 74卷 / 01期
关键词
RENAL CELL CARCINOMA; NEPHRECTOMY; IMMUNOLOGY;
D O I
10.1111/j.1464-410X.1994.tb16538.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine the effects of nephrectomy on the immune response of patients with renal cell carcinoma (RCC). Patients and methods Five patients with RCC were monitored before and oner a period of up to 3 months after nephrectomy. The aspects measured were the phenotypic expression of markers on circulating lymphocytes, circulating concentrations of cytokines, markers of inflammatory and immune responses, and natural killer (NK) cell and lymphokine-activated killer (LAK) cell activity in peripheral blood mononuclear cells (PBMC). The suppressive activity of patients' plasma on NK activity and ability to generate interleukin-2 (IL-2) induced LAK cells in PBMC of normal volunteers was also investigated. Results The results indicated that high CD4/8 ratios were present pre-nephrectomy with evidence of inflammatory responses and immune activation in some patients, particularly those with metastatic disease. Conclusion The effect of nephrectomy was to decrease the inflammatory response and increase immune activation. Various defects in NK cell activity and LAK cell generation were demonstrated pre-surgery which slowly improved once the primary tumour had been removed and it is suggested that such defects could have contributed to tumour growth and development due to an ineffective immune response.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 21 条
  • [1] CANCER, CYTOKINES, AND CYTOTOXIC-CELLS - INTERLEUKIN-2 IN THE IMMUNOTHERAPY OF HUMAN NEOPLASMS
    ATZPODIEN, J
    KIRCHNER, H
    [J]. KLINISCHE WOCHENSCHRIFT, 1990, 68 (01): : 1 - 11
  • [2] BELLDEGRUN A, 1991, SEMIN ONCOL, V18, P96
  • [3] BORINAGA AM, 1990, BRIT J HAEMATOL, V76, P476
  • [4] BOYUM A, 1974, TISSUE ANTIGENS, V4, P269
  • [5] INHIBITION OF LYMPHOKINE-ACTIVATED KILLER-CELL GENERATION BY BLOCKING FACTORS IN SERA OF PATIENTS WITH HEAD AND NECK-CANCER
    BUGIS, SP
    LOTZOVA, E
    SAVAGE, HE
    HESTER, JP
    RACZ, T
    SACKS, PG
    SCHANTZ, SP
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 31 (03) : 176 - 181
  • [6] LYMPHOCYTE STIMULATION IN UROLOGIC CANCER-PATIENTS
    CATALONA, WJ
    TARPLEY, JL
    CHRETIEN, PB
    CASTLE, JR
    [J]. JOURNAL OF UROLOGY, 1974, 112 (03) : 373 - 377
  • [7] THE DIAGNOSIS AND TREATMENT OF RENAL-CELL CARCINOMA
    DEKERNION, JB
    BERRY, D
    [J]. CANCER, 1980, 45 (07) : 1947 - 1956
  • [8] IMMUNE PROFILE IN METASTASIS
    HART, IR
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1989, 1 (05) : 900 - 903
  • [9] HENDERSON DC, 1991, CLIN EXP IMMUNOL, V83, P479
  • [10] HOLLAND JM, 1973, CANCER, V32, P1030, DOI 10.1002/1097-0142(197311)32:5<1030::AID-CNCR2820320502>3.0.CO